Welcome
Support Centre
09 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Prophylaxis against Postoperative Vomiting (PaPoV) study: a prospective, controlled randomised double-blind trial comparing antiemetic prophylaxis with ondansetron, cyclizine and placebo (normal saline) in children undergoing plastic genito-urinary (GU) procedures
ISRCTN ISRCTN08630314
ClinicalTrials.gov identifier
Public title Prophylaxis against Postoperative Vomiting (PaPoV) study: a prospective, controlled randomised double-blind trial comparing antiemetic prophylaxis with ondansetron, cyclizine and placebo (normal saline) in children undergoing plastic genito-urinary (GU) procedures
Scientific title
Acronym PaPoV
Serial number at source N0557102800
Study hypothesis To assess the incidence of postoperative vomiting in children undergoing genital plastic surgery in a prospective, randomised, double blind study comparing ondansetron with cyclizine and placebo (normal saline).
Ethics approval Not provided at time of registration
Study design Randomised double blind controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Signs and Symptoms: Vomiting
Participants - inclusion criteria Children undergoing elective plastic genito-urinary procedures between the ages of 3 and 5, American Society of Anesthesiologists (ASA) grade I & II. 55 Children in each group.
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/01/1997
Anticipated end date 30/09/2003
Status of trial Completed
Patient information material
Target number of participants 110
Interventions Prospective, controlled randomised double-blind trial.
Primary outcome measure(s) Number of vomits in the first 24 h from the time of extubation; doses of anti-emetics given because of vomiting in the first 24 h; time to first oral intake; complications (obtained retrospectively from case notes).
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The Dudley Group of Hospitals NHS Trust (UK)
Trial website
Publications 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12886917
Contact name Dr  Philip  Whitehurst
  Address Consultant Anaesthetist
Russells Hall Hospital
  City/town Dudley
  Zip/Postcode DY1 2HQ
  Country United Kingdom
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 09/07/2009
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central